12/5/2024
06:30 am
kalv
Q2/2024 10/31/2024 EPS -0.910 ZacksConsensus -0.920 ActVsEst 0.010 - Beat
Low
Report
kalvista pharmaceuticals, inc.
12/5/2024
06:30 am
kalv
Q2/2024 10/31/2024 EPS -0.910 ZacksConsensus -0.920 ActVsEst 0.010 - Beat
Low
Report
kalvista pharmaceuticals, inc.
12/5/2024
06:30 am
kalv
Q2/2024 10/31/2024 EPS -0.910 ZacksConsensus -0.920 ActVsEst 0.010 - Beat
Low
Report
kalvista pharmaceuticals, inc.
12/5/2024
06:30 am
kalv
Q2/2024 10/31/2024 EPS -0.910 ZacksConsensus -0.920 ActVsEst 0.010 - Beat
Low
Report
kalvista pharmaceuticals, inc.